Missed the updated IDSA histoplasmosis guideline? This easy-to-read FAQ covers what clinicians caring for pregnant patients need to know.
|Videos|August 3, 2020
Overcoming racism and unconscious bias with Drs. Vanessa Rogers and Shawna Nesbitt
Senior Editor Angie DeRosa and Associate Editor Lindsey Carr sat down with Drs. Vanessa Rogers and Shawna Nesbitt to discuss racism and unconscious bias in ob/gyn practice.
Advertisement
Advertisement
Related to this article
In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.
Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.
Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA grants priority review to elinzanetant for VMS in women receiving endocrine therapy for breast cancer
2
Q&A: Anita Nelson, MD, on etonogestrel implant's 5-year approval and REMS certification
3
Missed & Dismissed: The diagnostic gap starts in childhood
4
CD38 is tied to age-related placental NAD+ decline in preclinical study
5